Yanchen Li

Senior Director, Pharmaceutical Collaboration Genetron Health

Seminars

Thursday 25th September 2025
Regulation Consideration of CTA & CDx Strategy across US-China in MRCT
11:00 am
  • Understanding CTA and CDx regulation environment in china and beyond
  • Understanding IVD and CDx commercialization and payment environment in China
  • Regulation strategy and Dx choice in MRCT
  • Genetron Global: Advancing MRD detection (heme and solid tumors) and cross border CTA to CDx solutions
Yanchen Li Yasiejko